High Risk of Suicide in Behavioral Variant Frontotemporal Dementia.


Journal

American journal of Alzheimer's disease and other dementias
ISSN: 1938-2731
Titre abrégé: Am J Alzheimers Dis Other Demen
Pays: United States
ID NLM: 101082834

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 19 12 2018
medline: 22 4 2020
entrez: 19 12 2018
Statut: ppublish

Résumé

The purpose of the study was to determine the prevalence of suicidal ideation and attempts in patients with behavioral variant frontotemporal dementia (bvFTD), evaluating possible risk factors for suicidality. Risk of suicide was assessed using the Scale for Suicide Ideation (SSI) in 35 patients with bvFTD and 25 controls. According to SSI, 40% of patients with bvFTD had suicidal ideation in comparison to 8% of controls ( P = .009). Four patients with bvFTD have attempted suicide versus none control ( P = .006). Patients with bvFTD with suicide risk showed higher levels of anxiety, depression, stress, and hopelessness than patients without suicide risk ( P < .001). Patients who attempted suicide were younger and had a longer disease duration than those with only suicide ideation. Intriguingly, 40% of patients with parkinsonism presented high level of suicide ideation. Our findings show that patients with bvFTD have a high risk of suicide. Additional studies in larger populations are needed to confirm our results.

Identifiants

pubmed: 30558441
doi: 10.1177/1533317518817609
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-271

Commentaires et corrections

Type : CommentIn

Auteurs

Milena Zucca (M)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Elisa Rubino (E)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Alessandro Vacca (A)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Flora Govone (F)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Annalisa Gai (A)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Paola De Martino (P)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Silvia Boschi (S)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.
2 Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.

Salvatore Gentile (S)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Maria Teresa Giordana (MT)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Innocenzo Rainero (I)

1 Department of Neuroscience "Rita Levi Montalcini," Aging Brain and Memory Clinic, University of Torino, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH